Data Animal Data In pregnant rats given twice weekly subcutaneous doses of 0.02, 0.1, and 0.5 mg/kg tirzepatide [0.03-, 0.07-, and 0.5-fold the maximum recommended human dose (MRHD) of 15 mg once weekly based on AUC] during organogenesis, increased incidences of external, visceral, and skeletal malformations, increased incidences of visceral and skeletal developmental variations, and decreased fetal weights coincided with pharmacologically-mediated reductions in maternal body weights and food consumption at 0.5 mg/kg
Advances in nutrition (Bethesda, Md.) , 9 (1), 2129
The MHRA has not licensed AOD 9604 as a medicinal product in the UK, and its status can be confirmed via the MHRA's product licence search
AOD 9604 peptide appeared to exhibit action similar to hGH wherein both may be capable of increasing repressed levels of lipolytic receptors in obese mice as compared to the lean mice
Researchers investigate AHK-Cu because of its association with copper transport , extracellular matrix regulation, peptide-mediated signaling, connective tissue biology, and molecular communication
GHK-Cu (Copper) (50mg) Original price was: $69.00.$58.00Current price is: $58.00